Protection provided to children through parental vaccination with the BNT162b2 vaccine

NewsGuard 100/100 Score

Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has claimed more than 5.66 million lives worldwide. The pandemic is commonly known as the coronavirus disease 2019 (COVID-19) pandemic. Children had been perceived to be at lower risk, but they could still benefit indirectly from the vaccination administered to their contacts. In a new study published in Science, scientists estimated the protection provided to children by means of parental vaccination with the BNT162b2 vaccine.

Study: Indirect protection of children from SARS-CoV-2 infection through parental vaccination. Image Credit: ViDI Studio/ShutterstockStudy: Indirect protection of children from SARS-CoV-2 infection through parental vaccination. Image Credit: ViDI Studio/Shutterstock

Background

Several studies have documented that COVID-19 transmission is common in households, and a recent meta-analysis pinned down the attack rate at 19%. Therefore, to estimate the direct and indirect effects of vaccines, households serve as a viable alternative to large clusters. The direct benefits of the BNT162b2 vaccine have been widely documented in clinical trials. However, the indirect benefits are not well studied. A study in Israel revealed how the unvaccinated family members of health care workers were protected owing to the vaccination received by their spouses. However, more research is required to understand the issue better.

A new study

The integrated data repositories of Israel’s largest healthcare organization were used to estimate the indirect Vaccine Effectiveness (VE) of the BNT162b2 vaccine on unvaccinated children within households. The analysis was performed over two time periods. The first was an early period (January 17, 2021, through March 28, 2021) in children aged 16 years or less. This was the time when the Alpha variant dominated.

Researchers compared households where parents were vaccinated with the primary vaccine series with the households where parents were not vaccinated. The second period was a late period (July 11, 2021, through September 30, 2021), in which children <11 years were studied. At this time, the Delta variant was the dominant strain. In this wave, households with boosted parents were compared to households with parents who had received two doses of the vaccine but had not been boosted yet. In each period, the risk of SARS-CoV-2 among susceptible children was analyzed.

Key findings

During the early period, it was observed that a single vaccinated parent was associated with a 26.0% decreased risk of infection for children living in the same household. The risk of infection declined by 71.7% when both parents were vaccinated. This effect was robust across subject age groups and household sizes. During the late period, a single boosted parent was associated with a 20.8% decreased risk for infection, while two boosted parents were associated with a 58.1% decline. There was some heterogeneity between age groups and across household sizes.

Researchers also estimated the direct benefit of the vaccine in reducing documented infection. The efficacy was 94.4% for the early period, and for the later period, the efficacy was 86.3%. Full vaccination of an infected parent was associated with a 72.1% decreased chance of infection of one or more susceptible children in the household in the early period. In the late period, this number was 79.6%. The results indicated that even a single unvaccinated parent could introduce infection in the household, with a significant probability. 

Limitations

Scientists did not determine the fraction of infections arising from a source outside the household. Further, demographic data were used to determine household membership. It could well be that members of the same household live in different addresses. Next, infections were dated based on the date of sampling, which does not necessarily coincide with the date of infection, which could lead to biased estimates.

It is also possible that scientists did not account for certain confounders, particularly those related to behavior. Another possibility is that the outcomes were misclassified between the two study groups. Lastly, researchers could not rule out the collider stratification bias, owing to strong assumptions on which the computation of the secondary attack rate was based. 

Conclusion

Parental vaccination was observed to confer significant protection to children residing in the same household. Researchers also highlighted the mechanism through which this protection is conferred. The results obtained in this study underscore the importance of increasing vaccine uptake among eligible individuals. This would help protect them from the infection and indirectly confer protection to their near and dear ones who cannot be vaccinated.

Journal reference:
Dr. Priyom Bose

Written by

Dr. Priyom Bose

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bose, Priyom. (2022, January 31). Protection provided to children through parental vaccination with the BNT162b2 vaccine. News-Medical. Retrieved on April 29, 2024 from https://www.news-medical.net/news/20220131/Protection-provided-to-children-through-parental-vaccination-with-the-BNT162b2-vaccine.aspx.

  • MLA

    Bose, Priyom. "Protection provided to children through parental vaccination with the BNT162b2 vaccine". News-Medical. 29 April 2024. <https://www.news-medical.net/news/20220131/Protection-provided-to-children-through-parental-vaccination-with-the-BNT162b2-vaccine.aspx>.

  • Chicago

    Bose, Priyom. "Protection provided to children through parental vaccination with the BNT162b2 vaccine". News-Medical. https://www.news-medical.net/news/20220131/Protection-provided-to-children-through-parental-vaccination-with-the-BNT162b2-vaccine.aspx. (accessed April 29, 2024).

  • Harvard

    Bose, Priyom. 2022. Protection provided to children through parental vaccination with the BNT162b2 vaccine. News-Medical, viewed 29 April 2024, https://www.news-medical.net/news/20220131/Protection-provided-to-children-through-parental-vaccination-with-the-BNT162b2-vaccine.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global study reveals mismatch in COVID-19 treatment guidelines with WHO standards